Found: 107
Select item for more details and to access through your institution.
Correction to: Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers.
- Published in:
- European Radiology, 2021, v. 31, n. 8, p. 6001, doi. 10.1007/s00330-020-07598-8
- By:
- Publication type:
- Article
Optimization and validation of <sup>18</sup>F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer.
- Published in:
- PLoS ONE, 2023, v. 18, n. 11, p. 1, doi. 10.1371/journal.pone.0293672
- By:
- Publication type:
- Article
Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0-1 non-small cell lung cancer: the INCREASE trial.
- Published in:
- 2020
- By:
- Publication type:
- Journal Article
The intra- and interobserver variability of PSMA-expression scores in patients with primary prostate cancer.
- Published in:
- EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01152-z
- By:
- Publication type:
- Article
Dual-Phase PET-CT to Differentiate [<sup>18</sup>F]Fluoromethylcholine Uptake in Reactive and Malignant Lymph Nodes in Patients with Prostate Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0048430
- By:
- Publication type:
- Article
Quantitative implications of the updated EARL 2019 PET–CT performance standards.
- Published in:
- EJNMMI Physics, 2019, v. 6, n. 1, p. 1, doi. 10.1186/s40658-019-0257-8
- By:
- Publication type:
- Article
Head-To-Head Comparison of PET and Perfusion Weighted MRI Techniques to Distinguish Treatment Related Abnormalities from Tumor Progression in Glioma.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2631, doi. 10.3390/cancers15092631
- By:
- Publication type:
- Article
Prostate-Specific Membrane Antigen Targeted Pet/CT Imaging in Patients with Colon, Gastric and Pancreatic Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6209, doi. 10.3390/cancers14246209
- By:
- Publication type:
- Article
Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1169, doi. 10.3390/cancers14051169
- By:
- Publication type:
- Article
Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6164, doi. 10.3390/cancers13246164
- By:
- Publication type:
- Article
Irreversible Electroporation and Nivolumab Combined with Intratumoral Administration of a Toll-Like Receptor Ligand, as a Means of In Vivo Vaccination for Metastatic Pancreatic Ductal Adenocarcinoma (PANFIRE-III). A Phase-I Study Protocol.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3902, doi. 10.3390/cancers13153902
- By:
- Publication type:
- Article
Response Prediction and Evaluation Using PET in Patients with Solid Tumors Treated with Immunotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 3083, doi. 10.3390/cancers13123083
- By:
- Publication type:
- Article
Standardised lesion segmentation for imaging biomarker quantitation: a consensus recommendation from ESR and EORTC.
- Published in:
- Insights into Imaging, 2022, v. 13, n. 1, p. 1, doi. 10.1186/s13244-022-01287-4
- By:
- Publication type:
- Article
Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.772530
- By:
- Publication type:
- Article
Sensitivity of <sup>18</sup>F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer.
- Published in:
- EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0531-8
- By:
- Publication type:
- Article
Clinical verification of <sup>18</sup>F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0239414
- By:
- Publication type:
- Article
M1a prostate cancer: Results of a Dutch multidisciplinary consensus meeting.
- Published in:
- BJUI Compass, 2021, v. 2, n. 3, p. 159, doi. 10.1002/bco2.73
- By:
- Publication type:
- Article
Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial.
- Published in:
- 2021
- By:
- Publication type:
- Letter
A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267260
- By:
- Publication type:
- Article
A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 6, p. 888, doi. 10.2967/jnumed.123.267260
- By:
- Publication type:
- Article
PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1526, doi. 10.2967/jnumed.123.265738
- By:
- Publication type:
- Article
The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 8, p. 1238, doi. 10.2967/jnumed.122.265205
- By:
- Publication type:
- Article
Reproducibility of PSMA PET/CT imaging for primary staging of treatment-naïve prostate cancer patients depends on the applied radiotracer: a retrospective study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263139
- By:
- Publication type:
- Article
Reproducibility of PSMA PET/CT imaging for primary staging of treatment-naïve prostate cancer patients depends on the applied radiotracer: a retrospective study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263139
- By:
- Publication type:
- Article
Biodistribution of <sup>18</sup>F-FES in patients with metastatic ER+ breast cancer undergoing treatment with Rintodestrant (G1T48), a novel selective estrogen receptor degrader.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262500
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F‐DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim 18F‐FDG PET in DLBCL.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.258673
- By:
- Publication type:
- Article
Biodistribution of <sup>18</sup>F-FES in patients with metastatic ER+ breast cancer undergoing treatment with Rintodestrant (G1T48), a novel selective estrogen receptor degrader.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262500
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small- cell lung cancer . .
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional 18F‐DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim <sup>18</sup>F‐FDG PET in DLBCL.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.258673
- By:
- Publication type:
- Article
Biodistribution of <sup>18</sup>F-FES in patients with metastatic ER+ breast cancer undergoing treatment with Rintodestrant (G1T48), a novel selective estrogen receptor degrader.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262500
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of<sup> 89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F‐DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim 18F‐FDG PET in DLBCL.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.258673
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim 18F-FDG PET in DLBCL.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.258673
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
Standardized Uptake Values are Adequate Measures of Lesional <sup>18</sup>F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.260232
- By:
- Publication type:
- Article
Interobserver agreement in automated metabolic tumor volume measurements of Deauville score 4 and 5 lesions at interim 18F-FDG PET in DLBCL.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.258673
- By:
- Publication type:
- Article